EXOZYMES INC. Shareholders' Equity
EXOZYMES INC. (EXOZ) had Shareholders' Equity of $3.65 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $3.65M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.53M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.40M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $5.37M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $3.65M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.53M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $3.40M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $5.37M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $7.24M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $8.88M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $10.42M 10-Q · filed 2026-08-13 |
| 2024-09-30 | -$3.60M 10-Q · filed 2025-11-13 |
| 2024-06-30 | -$2.26M 10-Q · filed 2025-11-13 |
| 2024-03-31 | -$1.25M 10-Q · filed 2025-11-13 |
| 2023-12-31 | -$384.32K 10-K · filed 2026-03-30 |
| 2023-09-30 | $607.14K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $1.07M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $1.19M 10-Q · filed 2024-11-12 |
| 2022-12-31 | $1.37M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |